Back to Clinical Trials
Phase 1Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

Sponsored by Bristol-Myers Squibb

About this study

The purpose of this study is to evaluate the safety, tolerability, and efficacy of escalating doses of BMS-986463 in participants with select advanced malignant tumors.

Where this study is enrolling (3)

  • USC/Norris Comprehensive Cancer Center

    Los Angeles, California

    Call 310-226-2905

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Valkyrie Clinical Trials

    Los Angeles, California

    Call 424-535-1874

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • John Theurer Cancer Center at Hackensack University Medical Center

    Hackensack, New Jersey

    Call 551-996-5863

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

Who can participate

Inclusion criteria

  • ✓Participants must have an Eastern Cooperative Oncology Group Performance Status of 0 or 1.
  • ✓Participants must have at least 1 lesion accessible for biopsy in addition to the target lesion, from which a fresh pre treatment biopsy must be obtained.
  • ✓Participants must have an unresectable/metastatic carcinoma.

Exclusion criteria

  • ✕Participants must not have Leptomeningeal metastases.
  • ✕Participants must not have concurrent malignancy (present during screening) requiring treatment or history of prior malignancy active within 2 years prior to treatment.
  • ✕Participants must not have had any prior radiation therapy within 2 weeks prior to start of study treatment.
  • ✕Other protocol-defined Inclusion/Exclusion criteria apply.

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.